HN1998000073A - Derivados de la 9 - oxima eritromicina - Google Patents

Derivados de la 9 - oxima eritromicina

Info

Publication number
HN1998000073A
HN1998000073A HN1998000073A HN1998000073A HN1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A
Authority
HN
Honduras
Prior art keywords
compounds
derivatives
oxima
erythromycin
well
Prior art date
Application number
HN1998000073A
Other languages
English (en)
Spanish (es)
Inventor
Yong Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1998000073A publication Critical patent/HN1998000073A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HN1998000073A 1997-06-11 1998-05-19 Derivados de la 9 - oxima eritromicina HN1998000073A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
HN1998000073A true HN1998000073A (es) 1999-01-08

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1998000073A HN1998000073A (es) 1997-06-11 1998-05-19 Derivados de la 9 - oxima eritromicina

Country Status (31)

Country Link
EP (1) EP0988308A1 (id)
JP (1) JP2000513026A (id)
KR (1) KR20010013660A (id)
CN (1) CN1259135A (id)
AP (1) AP9801253A0 (id)
AR (1) AR012244A1 (id)
AU (1) AU7226798A (id)
BG (1) BG103947A (id)
BR (1) BR9810021A (id)
CA (1) CA2293335A1 (id)
CO (1) CO4940506A1 (id)
CZ (1) CZ9904388A3 (id)
EA (1) EA199901016A1 (id)
GT (1) GT199800074A (id)
HN (1) HN1998000073A (id)
HR (1) HRP980316A2 (id)
HU (1) HUP0002252A3 (id)
ID (1) ID24529A (id)
IL (1) IL132767A0 (id)
IS (1) IS5251A (id)
MA (1) MA26505A1 (id)
NO (1) NO996108L (id)
OA (1) OA11225A (id)
PA (1) PA8451801A1 (id)
PE (1) PE79899A1 (id)
PL (1) PL337606A1 (id)
TN (1) TNSN98083A1 (id)
TR (1) TR199902995T2 (id)
TW (1) TW448174B (id)
WO (1) WO1998056800A1 (id)
ZA (1) ZA985018B (id)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
WO2000017218A1 (en) 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
KR100710605B1 (ko) * 1999-04-16 2007-04-24 코산 바이오사이언시즈, 인코포레이티드 매크롤라이드 항감염제
JP2003500414A (ja) 1999-05-24 2003-01-07 ファイザー・プロダクツ・インク １３−メチルエリスロマイシン誘導体
MXPA01012661A (es) * 1999-06-07 2002-07-22 Abbott Lab Derivados de 6-o-carbamato quetolida.
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8796232B2 (en) 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
WO2011119604A1 (en) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20180110181A (ko) 2010-09-10 2018-10-08 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
CN105163785A (zh) 2013-03-14 2015-12-16 森普拉制药公司 用于治疗呼吸道疾病的方法及其制剂
CA2907085A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
OA11225A (en) 2003-07-17
PA8451801A1 (es) 2000-05-24
GT199800074A (es) 1999-11-27
AU7226798A (en) 1998-12-30
TNSN98083A1 (fr) 2005-03-15
EA199901016A1 (ru) 2000-06-26
ID24529A (id) 2000-07-20
EP0988308A1 (en) 2000-03-29
CN1259135A (zh) 2000-07-05
AP9801253A0 (en) 1999-12-04
AR012244A1 (es) 2000-09-27
CA2293335A1 (en) 1998-12-17
ZA985018B (en) 1999-12-10
CZ9904388A3 (cs) 2002-10-16
BR9810021A (pt) 2000-09-19
NO996108L (no) 2000-02-10
TR199902995T2 (xx) 2000-02-21
PL337606A1 (en) 2000-08-28
CO4940506A1 (es) 2000-07-24
TW448174B (en) 2001-08-01
IL132767A0 (en) 2001-03-19
IS5251A (is) 1999-11-16
HUP0002252A3 (en) 2002-01-28
HUP0002252A2 (hu) 2000-12-28
KR20010013660A (ko) 2001-02-26
BG103947A (en) 2000-07-31
PE79899A1 (es) 1999-08-25
NO996108D0 (no) 1999-12-10
WO1998056800A1 (en) 1998-12-17
MA26505A1 (fr) 2004-12-20
HRP980316A2 (en) 1999-04-30
JP2000513026A (ja) 2000-10-03

Similar Documents

Publication Publication Date Title
HN1998000073A (es) Derivados de la 9 - oxima eritromicina
GT199800075A (es) Derivados de macrolidos c-4" sustituidos.
PA8461701A1 (es) Derivados de 9-amino-3-ceto eritromicina
UY25330A1 (es) Nuevos macrólidos
ATE311209T1 (de) Kombinationen von antiseptischen und antibiotischen mitteln enthaltende medizinische vorrichtungen
PA8524501A1 (es) Antibioticos macrolidos
GT199700124A (es) Derivados de aminas biciclicas
ES2054867T3 (es) Plaguicidas y pesticidas.
PA8462201A1 (es) Compuestos de benceno sustituidos, procedimientos para su preparacion, y composiciones herbicidas y defoliantes que los contienen
GT199900192A (es) Nuevos antibioticos macrolidos.
BR9407711A (pt) Composto de ciclopeptídeo processo para preparaçao de um composto de ciclopeptídeo e parasiticida
DK41791D0 (da) Antibiotikum cc 1065-analoge
GT199900198A (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
GT199800162A (es) Derivados de eritromicina triciclicos.
AR027688A1 (es) Acilsulfimidas heterociclicas, procedimiento para su preparacion, agentes que las contienen y su empleo como agentes para combatir animales perjudiciales
ES2055808T3 (es) Agente para la proteccion de plantas contra enfermedades.
GT200000049A (es) Compuestos quimicos.
AR004664A1 (es) Compuestos de dihalopropeno, insecticidas que los contienen como ingredientes activos, y compuestos intermedios para su produccion
GT199700104A (es) Procedimientos e intermedios para preparar derivados de cromanol sustituidos.
DK0410615T3 (da) Antiparasitisk middel
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
BR8504387A (pt) Processo para preparacao de derivados de sacarina acilados,composicoes pesticidas e processos para o combate a pragas e para a preparacao de composicoes
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
FI960486A0 (fi) Loislääkkeitä
HN1999000064A (es) Derivados de 2 "-desoxi higromicina"